Fundz

Aktis Oncology reported raising $175 Million in an initial SEC Form D filing, from an offering of $175 Million

PUBLIC · AKTSOct 02, 2024

Amount Raised

$175 Million

$175 Million sold, per SEC Form D (first sale Sep 20, 2024)

Round Type

Venture

BostonBiotechnologyHealth CareTherapeutics

Investors

Janus HendersonRA Capital Management

Quick answer

Aktis Oncology raised $175 Million in a funding round, dated September 20, 2024. Investors: Janus Henderson and RA Capital Management. Aktis Oncology is based in Boston, Massachusetts, United States.

How much did Aktis Oncology raise?
Aktis Oncology raised $175 Million in a funding round on September 20, 2024.
Who invested in Aktis Oncology?
Janus Henderson and RA Capital Management are named as investors in this round.
What does Aktis Oncology do?
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.
Where is Aktis Oncology based and how big is it?
Aktis Oncology is based in Boston, Massachusetts, United States. Fundz records about 41 employees.
Who are the decision-makers at Aktis Oncology?
Fundz holds 1 contact at Aktis Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Aktis Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
  • CrossBridge Bio raised $10M (Seed) on November 4, 2024.
  • Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.
  • Archon Biosciences raised $20M (Seed) on October 30, 2024.
  • SynOx Therapeutics raised $92M (Series B) on October 30, 2024.
  • Tempero Bio raised $77M on October 30, 2024.

Who to call at Aktis Oncology, and when

A new round usually means Aktis Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aktis Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aktis Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aktis Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aktis Oncology

Location

Boston, Massachusetts, United States

About

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aktis Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aktis Oncology's next move

See what Strategic adds

Aktis Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.